A secondary analysis of FDG spatio-temporal consistency in the randomized phase II PET-boost trial in stage II-III NSCLC.

MLA

La Fontaine, Matthew, et al. “A Secondary Analysis of FDG Spatio-Temporal Consistency in the Randomized Phase II PET-Boost Trial in Stage II-III NSCLC.” Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, vol. 127, no. 2, May 2018, pp. 259–66. EBSCOhost, https://doi.org/10.1016/j.radonc.2018.03.020.

APA

La Fontaine, M., Vogel, W., van Diessen, J., van Elmpt, W., Reymen, B., Persson, G., Westman, G., De Ruysscher, D., Belderbos, J., & Sonke, J.-J. (2018). A secondary analysis of FDG spatio-temporal consistency in the randomized phase II PET-boost trial in stage II-III NSCLC. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, 127(2), 259–266. https://doi.org/10.1016/j.radonc.2018.03.020

Chicago

La Fontaine, Matthew, Wouter Vogel, Judi van Diessen, Wouter van Elmpt, Bart Reymen, Gitte Persson, Gunnar Westman, Dirk De Ruysscher, José Belderbos, and Jan-Jakob Sonke. 2018. “A Secondary Analysis of FDG Spatio-Temporal Consistency in the Randomized Phase II PET-Boost Trial in Stage II-III NSCLC.” Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology 127 (2): 259–66. doi:10.1016/j.radonc.2018.03.020.